Related Experiment Video
Updated: Nov 7, 2025

09:54
Laboratory Scale Production and Purification of a Therapeutic Antibody
Published on: January 24, 2017
17.9K
Optimization of therapeutic antibodies
Bo Wang1, Sachith Gallolu Kankanamalage1, Jianbo Dong1
1Ab Studio, Inc. Hayward, CA 94545, USA.
Antibody Therapeutics
|April 30, 2021
Summary
Therapeutic antibody optimization is crucial for drug development. Engineering antibodies using display technology, computational design, and mutagenesis enhances safety, efficacy, and developability for better drug candidates.
Area of Science:
- Biotechnology
- Immunology
- Pharmaceutical Sciences
Background:
- Therapeutic antibodies are vital in modern medicine, but their development requires extensive optimization.
- Ensuring antibody safety, efficacy, and manufacturability is a significant challenge in pharmaceutical development.
Purpose of the Study:
- To review current strategies for optimizing therapeutic antibodies.
- To highlight methods for improving antibody properties essential for successful drug development.
Main Methods:
- Engineering antibodies using display technologies.
- Employing computer-aided design (CAD) for antibody optimization.
- Utilizing site-directed mutagenesis to refine antibody characteristics.
Main Results:
- Optimization techniques can enhance antigen binding affinity and specificity.
- Biological efficacy, pharmacokinetics, and pharmacodynamics are improvable through engineering.
- Strategies exist to reduce immunogenicity and improve physicochemical developability.
Conclusions:
- A comprehensive, best-in-class strategy optimizes multiple antibody properties simultaneously.
- Successful therapeutic antibody development relies on a holistic optimization approach.
Keywords:
affinityantibody developabilityantibody efficacyantibody optimizationantibody safetyantibody therapycomputer-aided designhumanizationmaturationMore Related Videos
Related Concept Videos
Hybridoma Technology
16.4K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
16.4K
Immunoprecipitation
6.3K
Immunoprecipitation, or IP, is a widely used technique that employs protein-antibody interactions to isolate proteins or protein complexes in their native state for studying protein-protein interactions, quaternary structures, or supramolecular complexes. Various modifications of the technique, including chromatin IP, cross-linking IP, and fluorescence IP, are commonly used.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...
6.3K

